IE 11 is not supported. For an optimal experience visit our site on another browser.

Akshay Syal, M.D.

Akshay Syal, M.D., is a medical fellow with the NBC News Health and Medical Unit. Follow him on Twitter @AkshaySyal 

Akshay Syal, M.D., is a medical fellow with the NBC News Health and Medical Unit. Follow him on Twitter @AkshaySyal 

Latest from Akshay Syal, M.D.

20d ago

Many patients hospitalized for other ailments are also testing positive for Covid

As omicron variant spreads, hospital patients admitted for other ailments are also testing positive.
42d ago

A poorly matched flu shot could mean a bad flu season on top of a Covid surge

The current flu vaccines appear to be a bad match for the dominant strain so far this influenza season. That could lead to a bad flu season onto of a Covid surge.
42d ago

Could mRNA vaccines be the next frontier of cancer treatment?

German drugmaker BioNTech is enrolling patients in a clinical trial to test its mRNA vaccine for colon cancer relapse.
52d ago

Pfizer vaccine may be less effective against omicron, early lab data indicate

Data from South Africa show the Pfizer vaccine is less effective against the omicron variant. There was a 40-fold reduction in neutralizing antibodies.
56d ago

Do vaccines work against omicron? Lab studies are coming, but won't tell whole story.

Do the vaccines protect against the omicron variant? Lab study results are expected soon, but more research will also be needed.
71d ago

FDA authorizes Pfizer and Moderna boosters for all adults

The FDA authorized Pfizer and Moderna booster shots for all adults. A CDC advisory panel will take up the issue on Friday.
72d ago

Hospitalizations rising among fully vaccinated in U.S., Fauci says

As cases of Covid-19 rise throughout the U.S., health officials warn that an increasing number of fully vaccinated people are being hospitalized going to the ER.
80d ago

Pfizer asks for FDA authorization for booster shots for everyone 18 and up

Pfizer is asking the FDA to authorize its booster shot for everyone ages 18 and up. The move would greatly expand booster access in the United States.
92d ago

Covid vaccines provide stronger immunity than past infection, CDC study finds

Vaccination offers stronger protection against Covid than a previous infection, according to a CDC study.
101d ago

Nation's vaccine experts debate goal of booster campaign

Are boosters meant to prevent infections? Or to keep people out of the hospital?
107d ago

'Mix and match' Covid vaccine boosters are effective, NIH study finds

Mix and match Covid vaccines could be a reality after an NIH study found them to be safe and effective.